Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
作者： GA Kim , TH Rim , SC Lee , SH Byeon , HJ Koh
DOI: 10.1038/EYE.2015.58
关键词: Glaucoma 、 Intravitreal bevacizumab 、 Ophthalmic pathology 、 Neuro-ophthalmology 、 Bevacizumab 、 Serous fluid 、 Ophthalmology 、 Fluorescein angiography 、 Medicine 、 Visual acuity
摘要: Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients
nature.com
elsevier.com
paperity.org参考文章(44)
Engin Burumcek, Abdulbaki Mudun, Serra Karacorlu, Mehmet O. Arslan, Laser Photocoagulation for Persistent Central Serous Retinopathy: Results of Long-term Follow-up Ophthalmology. ,vol. 104, pp. 616- 622 ,(1997) , 10.1016/S0161-6420(97)30262-0
Xiu-juan Li, Jin-song Zhang, Intravitreal bevacizumab injection for chronic central serous chorioretinopathy. Chinese Medical Journal. ,vol. 123, pp. 2145- 2147 ,(2010)
Lawrence A Yannuzzi, None, Type A behavior and central serous chorioretinopathy. Transactions of the American Ophthalmological Society. ,vol. 84, pp. 799- 845 ,(1986)
Ursula Schlötzer-Schrehard, Ursula Schmidt-Erfurth, Arne Viestenz, Gottfried O. H. Naumann, Horst Laqua, Histopathological changes following photodynamic therapy in human eyes. Archives of Ophthalmology. ,vol. 120, pp. 835- 844 ,(2002)
Karen B. Schaal, Alexandra E. Hoeh, Alexander Scheuerle, Florian Schuett, Stefan Dithmar, Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. European Journal of Ophthalmology. ,vol. 19, pp. 613- 617 ,(2009) , 10.1177/112067210901900415
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. ,vol. 114, pp. 1860- 1867 ,(2007) , 10.1016/J.OPHTHA.2007.05.062
Felice Cardillo Piccolino, Chiara M Eandi, Luca Ventre, Roberta C Rigault de la Longrais, Federico M Grignolo, Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmologica. ,vol. 88, pp. 371- 376 ,(2009) , 10.1111/J.1755-3768.2008.01408.X
Jared S Nielsen, Lee M Jampol, ORAL MIFEPRISTONE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY Retina. ,vol. 31, pp. 1928- 1936 ,(2011) , 10.1097/IAE.0B013E31821C3EF6
AKITAKA TSUJIKAWA, YUMIKO OJIMA, KENJI YAMASHIRO, SOTARO OOTO, HIROSHI TAMURA, SATOKO NAKAGAWA, NAGAHISA YOSHIMURA, Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 30, pp. 801- 809 ,(2010) , 10.1097/IAE.0B013E3181C72068
Tim U. Krohne, Nicole Eter, Frank G. Holz, Carsten H. Meyer, Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans American Journal of Ophthalmology. ,vol. 146, pp. 508- 512 ,(2008) , 10.1016/J.AJO.2008.05.036